Lantern Pharma Inc.

Lantern Pharma Inc. (LTRN) is a biopharmaceutical company focused on leveraging artificial intelligence (AI) and machine learning to accelerate the discovery and development of precision oncology therapeutics. The company's RADR® AI platform analyzes vast amounts of genomic, transcriptomic, and clinical data to identify patients most likely to respond to specific therapies and to rescue drug candidates that have failed in the past. Lantern Pharma aims to improve treatment outcomes for cancer patients by developing targeted therapies with higher probabilities of success. The company's pipeline includes several drug candidates in various stages of preclinical and clinical development, targeting a range of cancers. By employing its AI-driven approach, Lantern Pharma seeks to reduce the time and cost associated with traditional drug development, ultimately delivering innovative and effective cancer treatments to patients in need.